v3.26.1
Convertible Notes Payable (Tables) - DiamiR Biosciences Corp. [Member]
6 Months Ended 12 Months Ended
Nov. 30, 2025
May 31, 2025
Convertible Notes Payable [Line Items]    
Schedule of Convertible Notes Payable

Convertible notes payable consist of the following:

 

November 30,
2025

 

May 31,
2025

Executive director

 

$

1,060,565

 

$

872,245

Former Chief Scientific Officer

 

 

89,782

 

 

85,417

Investor

 

 

101,778

 

 

Total

 

$

1,252,125

 

$

957,662

Convertible notes payable consist of the following:

 

May 31,
2025

 

May 31,
2024

Executive director

 

$

872,245

 

$

536,861

Former Chief Scientific Officer

 

 

85,417

 

 

77,321

Total

 

$

957,662

 

$

614,182

Schedule of Interest Expenses

Interest expense consists of the following in the six months ended November 30:

 

2025

 

2024

Interest on notes

 

$

25,607

 

$

19,490

Amortization of discount

 

 

31,550

 

 

19,349

Total

 

$

57,157

 

$

38,839

Interest expense consists of the following in the years ended May 31:

 

2025

 

2024

Interest on notes

 

$

38,508

 

$

23,232

Amortization of discount

 

 

43,538

 

 

25,367

Total

 

$

82,046

 

$

48,599